What Ever Happened to Stem Cells?

This is an archived file of a live webcast that took place on February 18, 2016.

In this webinar we discuss the different kinds of stem cells (embryonic and induced pluripotent stem cells) and how researchers are using these tools to learn more about Parkinson's disease and develop new treatments. Before joining, read more on stem cells on our website.

This event is part of the MJFF Third Thursdays Webinar series. Visit www.michaeljfox.org/webinars for more information and to view past webinars.

Title: What Ever Happened to Stem Cells?

Duration: 1 hour

Continuing Medical Education Information for Health Care Professionals

Continuing Medical Education Information
MJFF offers Continuing Medical Education (CME) credit for practicing health care professionals for each Third Thursday Webinar. Click the link in the Resource List after viewing the webinar to take the post-test survey and receive your CME credit.

Date of Original Release: February 18, 2016
Date CME Credit No Longer Available: February 18, 2018

Learning Objectives
At the conclusion of this course, participants should be able to:

  • Define the role of stem cells.
  • Discuss the differences between embryonic and adult stem cells.
  • Describe induced pluripotent stem cells and how they are created.
  • Summarize previous research efforts in Parkinson's disease involving stem cells.
  • Identify how stem cells could potentially be used to treat Parkinson's disease symptoms.
  • Recognize how stem cells could potentially be used to learn more about the pathophysiology of Parkinson's disease.

Target Audience
This educational activity is designed for primary care physicians, family practice physicians, general medicine physicians, geriatricians, general neurologists, movement disorder specialists and any other health care practitioners who manage patients with Parkinson's disease.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Oakstone Publishing, LLC and The Michael J. Fox Foundation for Parkinson's Research. The Oakstone Publishing, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Oakstone Publishing, LLC designates this enduring material for 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing, LLC's planners, content reviewers, and editorial staff disclose no relevant commercial interests.

Ole Isacson, MD-PhD
Professor of Neurology/Neuroscience at Harvard Medical School
Founding Director of the Neuroregeneration Research Institute/ Neuroregeneration Laboratories at McLean Hospital
Principal Faculty of the Harvard Stem Cell Institute
No disclosures

Todd Sherer, PhD
CEO, The Michael J. Fox Foundation
No disclosures

Dave Iverson
No disclosures


Already Registered?

*Required Fields.

You must have Javascript and Cookies enabled to access this webcast. Click here for Help.

By registering you agree to receive email updates from
The Michael J. Fox Foundation. You can unsubscribe any time.